• $415.0M
    Market Cap
  • -19.60%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
05/31/2025
05/31/2024
05/31/2023
05/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
0
-100.00%
266,000
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
53,000
0.00%
53,000
N/A
Gross Profit
0
N/A
0
-100.00%
213,000
0.00%
213,000
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
N/A
N/A
-7.2M
+175.08%
-2.6M
-90.27%
-27.0M
-53.72%
Depreciation and Amortization Expense
18,000
-37.93%
29,000
-83.43%
175,000
-77.59%
781,000
-56.54%
Total Operating Expenses
-9.7M
-153.50%
18.1M
-55.50%
40.6M
-72.14%
145.6M
+39.22%
Operating Profit
9.7M
+153.50%
-18.1M
-55.50%
-40.6M
-72.09%
-145.4M
+39.01%
Interest Income
565,000
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
565,000
N/A
0
N/A
0
N/A
0
+100.00%
Total Nonoperating Income and Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Income before Taxes
3.7M
+107.51%
-49.8M
-37.56%
-79.8M
-62.14%
-210.8M
+36.30%
Income Taxes
0
N/A
0
N/A
0
N/A
0
N/A
Extraordinary Items
407,000
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
3.7M
+107.51%
-49.8M
-37.56%
-79.8M
-62.14%
-210.8M
+36.30%
Net Income from Continuing Operations Applicable to Common
3.7M
+107.51%
-49.8M
-37.56%
-79.8M
-62.14%
-210.8M
+36.30%
Basic EPS and Net Income
0.00
+100.00%
-0.05
-50.00%
-0.10
-67.74%
-0.31
N/A
Diluted EPS and Net Income
0.00
+100.00%
-0.05
-50.00%
-0.10
-67.74%
-0.31
+14.81%
Basic Weighted Average Shares
1.2B
+24.37%
969.5M
+15.90%
836.5M
+23.58%
676.9M
+15.20%
Diluted Weighted Average Shares
1.2B
+28.20%
969.5M
+15.90%
836.5M
+23.58%
676.9M
+15.20%
Balance Sheet
Cash and Cash Equivalents
11.9M
+282.73%
3.1M
+22.39%
2.5M
-39.94%
4.2M
-87.53%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
11.9M
+282.73%
3.1M
+22.39%
2.5M
-39.94%
4.2M
-87.53%
Total Current Assets
17.9M
+65.31%
10.8M
+0.09%
10.8M
+2.76%
10.5M
-91.89%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
73,000
-45.52%
Total Long-Term Assets
169,000
-47.35%
321,000
-34.09%
487,000
+567.12%
73,000
-45.52%
Total Assets
18.0M
+62.06%
11.1M
-1.38%
11.3M
-61.31%
29.2M
-77.90%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
27.2M
-8.70%
29.8M
-13.44%
34.4M
-5.03%
36.2M
-46.66%
Total Current Liabilities
70.5M
-16.23%
84.2M
-29.73%
119.8M
-2.73%
123.2M
-19.26%
Total Long-Term Debt
16.4M
+2,199.44%
714,000
0.00%
714,000
-99.15%
84.4M
+901.42%
Total Long-Term Liabilities
43.6M
0.00%
43.6M
+15,296.11%
283,000
-32.94%
422,000
-23.55%
Total Liabilities
114.1M
-10.79%
127.9M
+5.88%
120.8M
-2.26%
123.6M
-19.28%
Retained Earnings
-887.8M
-0.42%
-891.5M
+5.92%
-841.7M
+9.86%
-766.1M
+49.84%
Total Stockholders Equity
-96.0M
-17.74%
-116.8M
+6.63%
-109.5M
+16.00%
-94.4M
+349.13%
Total Shares Outstanding
1.2B
+18.01%
1.1B
+15.23%
918.6M
+27.66%
719.6M
+15.01%
Cash Flow
Cash from Operating Activities
-8.8M
-20.19%
-11.0M
-56.26%
-25.1M
-67.69%
-77.7M
-33.89%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
122,000
0.00%
Cash from Investing Activities
N/A
N/A
N/A
N/A
N/A
N/A
-122,000
0.00%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
10.9M
-7.61%
11.7M
-60.74%
29.9M
-37.67%
48.0M
-65.04%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
80.08%
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
-54,663.16%
N/A
Return on Assets
25.67%
+105.77%
-444.45%
+12.69%
-394.42%
+50.85%
-261.46%
+54.33%
Return on Equity
-3.52%
-107.99%
44.06%
-43.73%
78.30%
-78.57%
365.32%
-72.25%
Revenue Growth
N/A
N/A
N/A
N/A
-100.00%
N/A
N/A
N/A
Current Ratio
0.25
+97.28%
0.13
+42.46%
0.09
+5.62%
0.09
-89.95%
Cash Ratio
0.17
+357.45%
0.04
+74.06%
0.02
-38.37%
0.03
-84.54%
Debt-to-Equity Ratio
-0.45
+73.82%
-0.26
-18.55%
-0.32
-74.90%
-1.28
-64.82%
Debt-to-Assets Ratio
2.42
-11.78%
2.74
-11.94%
3.11
-24.76%
4.13
+614.97%

Earnings & Revenue History

Debt-to-Assets

Cash Flow